These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
    Author: Prussick L, Plotnikova N, Gottlieb A.
    Journal: J Drugs Dermatol; 2016 Jun 01; 15(6):715-8. PubMed ID: 27272078.
    Abstract:
    Atopic Dermatitis (AD) is a chronic inflammatory skin disease that is a significant cause of morbidity, quality-of-life impairment and health-care costs. Although many patients can be treated satisfactorily with topical medications and phototherapy, a smaller subset requires more aggressive systemic therapies. Multiple studies have shown promise for the use of mycophenolate mofetil (MMF) to treat refractory AD. This report summarizes the evidence for use of MMF in the treatment of recalcitrant AD for both children and adults. Familiarity with these studies on the benefits and risks of MMF will enable the clinician and patient to select the most appropriate therapy.<br /><br /> <em>J Drugs Dermatol</em>. 2016;15(6):715-718.
    [Abstract] [Full Text] [Related] [New Search]